olaparib zytiga for metastatic castrate-resistant prostate cancer | learn about clinical trials
Published 4 years ago • 4.3K plays • Length 3:48Download video MP4
Download video MP3
Similar videos
-
5:14
olaparib and keytruda for advanced prostate cancer | | learn about clinical trials
-
2:59
niraparib and abiraterone acetate for metastatic castration-resistant prostate cancer
-
5:15
rucaparib and olaparib: two new treatments approved for advanced prostate cancer | pcri
-
3:30
2020 in review: olaparib & rucaparib, fda approval | ask a prostate expert, mark scholz, md
-
5:05
castrate resistant, non-metastatic prostate cancer (m0 state) | prostate cancer staging guide
-
4:42
androgen annihilation in high-risk biochemically relapsed prostate cancer | learn clinical trials
-
3:07
propel: olaparib plus abiraterone as 1l treatment for metastatic crpc
-
11:57
#prostatecancer clinical trials: the benefits and risks | #markscholzmd #pcri
-
3:56
about metastatic castrate-resistant prostate cancer
-
4:23
apalutamide for high-risk prostate cancer | learn about clinical trials
-
3:50
darolutamide (nubeqa) lupron for high risk prostate cancer | learn about clinical trials
-
9:59
profound performance: olaparib vs. enzalutamide or abiraterone for hrr altered mcrpc
-
3:41
olaparib plus abiraterone could be a new first-line treatment option for mcrpc | fred saad
-
4:56
fred saad, esmo 2022: phase iii propel trial of abiraterone olaparib in prostate cancer
-
0:36
treating patients with progressive metastatic castration-resistant prostate cancer
-
1:15
exciting times for hormone-sensitive prostate cancer treatment
-
6:11
introduction to advanced prostate cancer (royal stage) | prostate cancer staging guide
-
14:53
finding & choosing clinical trials for #prostatecancer | #markscholzmd #alexscholz #pcri
-
1:10
abiraterone: a new therapy for metastatic prostate cancer | memorial sloan kettering